190 related articles for article (PubMed ID: 30978309)
21. [Intraocular invasion of bilateral primary ocular adnexal mantle cell lymphoma: a case report].
Wei M; Chen H; Wang JH; Shuai J; Ji M
Zhonghua Yan Ke Za Zhi; 2023 Jan; 59(1):52-56. PubMed ID: 36631059
[TBL] [Abstract][Full Text] [Related]
22. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
[TBL] [Abstract][Full Text] [Related]
23. [Treatment for mantle cell lymphoma].
Izutsu K
Rinsho Ketsueki; 2017; 58(10):2026-2032. PubMed ID: 28978845
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone b-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients.
Cho EY; Han JJ; Ree HJ; Ko YH; Kang YK; Ahn HS; Ahn SD; Park CJ; Huh J
Am J Hematol; 2003 Jun; 73(2):87-96. PubMed ID: 12749009
[TBL] [Abstract][Full Text] [Related]
25. Primary gastrointestinal tract mantle cell lymphoma as multiple lymphomatous polyposis.
Ruskoné-Fourmestraux A; Audouin J
Best Pract Res Clin Gastroenterol; 2010 Feb; 24(1):35-42. PubMed ID: 20206107
[TBL] [Abstract][Full Text] [Related]
26. Intraocular mantle cell lymphoma of the iris.
Reid JP; Puglis CL; Slagle WS
Optom Vis Sci; 2014 Apr; 91(4 Suppl 1):S25-9. PubMed ID: 24637484
[TBL] [Abstract][Full Text] [Related]
27. Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.
Pinnix CC; Dabaja BS; Milgrom SA; Smith GL; Abou Z; Nastoupil L; Romaguera J; Turturro F; Fowler N; Fayad L; Westin J; Neelapu S; Fanale MA; Rodriguez MA; Hagemeister F; Lee HJ; Oki Y; Wang M; Samaniego F; Chi L; Esmaeli B
Head Neck; 2017 Jun; 39(6):1095-1100. PubMed ID: 28370694
[TBL] [Abstract][Full Text] [Related]
28. [A patient with mantle cell lymphoma who successfully underwent auto-PBSCT in combination with in vivo purging of tumor cells using rituximab].
Kanaji N; Ishibashi K; Uno H; Hino N
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2569-72. PubMed ID: 12506485
[TBL] [Abstract][Full Text] [Related]
29. Outcome and prognostic factors in ocular adnexal lymphoma.
Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
[TBL] [Abstract][Full Text] [Related]
30. Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion.
Magni M; Di Nicola M; Devizzi L; Matteucci P; Lombardi F; Gandola L; Ravagnani F; Giardini R; Dastoli G; Tarella C; Pileri A; Bonadonna G; Gianni AM
Blood; 2000 Aug; 96(3):864-9. PubMed ID: 10910898
[TBL] [Abstract][Full Text] [Related]
31. Primary gastric mantle cell lymphoma in a patient with long standing history of Crohn's disease.
Raderer M; Püspök A; Birkner T; Streubel B; Chott A
Leuk Lymphoma; 2004 Jul; 45(7):1459-62. PubMed ID: 15359648
[TBL] [Abstract][Full Text] [Related]
32. Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type.
White WL; Ferry JA; Harris NL; Grove AS
Ophthalmology; 1995 Dec; 102(12):1994-2006. PubMed ID: 9098307
[TBL] [Abstract][Full Text] [Related]
33. Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification. Revised European and American Lymphoma.
Auw-Haedrich C; Coupland SE; Kapp A; Schmitt-Gräff A; Buchen R; Witschel H
Br J Ophthalmol; 2001 Jan; 85(1):63-9. PubMed ID: 11133714
[TBL] [Abstract][Full Text] [Related]
34. CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma of ocular adnexal origin: usefulness of fluorescence in situ hybridization for distinction between mantle cell lymphoma and MALT lymphoma.
Tasaki K; Shichishima A; Furuta M; Yoshida S; Nakamura N; Abe M
Pathol Int; 2007 Feb; 57(2):101-7. PubMed ID: 17300675
[TBL] [Abstract][Full Text] [Related]
35. Lymphomatous proptosis as a novel feature of mantle cell lymphoma.
Hon C; Chan RT; Ma ES; Shek TW; Yau K; Au WY
Leuk Lymphoma; 2006 Jan; 47(1):71-5. PubMed ID: 16321830
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic management of ocular adnexal MALT lymphoma.
Ferreri AJ; Assanelli A; Crocchiolo R; Dognini GP; Resti AG; Politi LS; Doglioni C; Cappio FC; Dolcetti R; Ponzoni M
Expert Opin Pharmacother; 2007 Jun; 8(8):1073-83. PubMed ID: 17922636
[TBL] [Abstract][Full Text] [Related]
37. Four Lymphomas in 1 Patient: A Unique Case of Triple Composite Non-Hodgkin Lymphoma Followed by Classical Hodgkin Lymphoma.
Tennese A; Skrabek PJ; Nasr MR; Sekiguchi DR; Morales C; Brown TC; Weisenburger DD; Perry AM
Int J Surg Pathol; 2017 May; 25(3):276-280. PubMed ID: 27688525
[TBL] [Abstract][Full Text] [Related]
38. Current trials for frontline therapy of mantle cell lymphoma.
Steiner RE; Romaguera J; Wang M
J Hematol Oncol; 2018 Jan; 11(1):13. PubMed ID: 29374487
[TBL] [Abstract][Full Text] [Related]
39. Mantle Cell Lymphoma With Hodgkin and Reed-Sternberg Cells: Review With Illustrative Case.
Kramer S; Uppal G; Wang ZX; Gong JZ
Appl Immunohistochem Mol Morphol; 2019 Jan; 27(1):8-14. PubMed ID: 28549034
[TBL] [Abstract][Full Text] [Related]
40. Mantle cell lymphoma diagnosed by conjunctival salmon-pink lesion biopsy.
Matsuo T; Ichimura K; Kubonishi S
J Clin Exp Hematop; 2014; 54(2):143-7. PubMed ID: 25318947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
